PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy
Researchers are trying to determine the side effects on the heart from immune checkpoint inhibitor (ICI) treatment in patients with cancer.
Cancer
DIAGNOSTIC_TEST: PET/CT|DRUG: radioactive drug (tracer)
Microvascular Damage/Endothelial Dysfunction, Number of subjects to develop microvascular damage/endothelial dysfunction as determined by the PET/CT scan.

PET-CT MFR used to assess dynamic changes in MFR that occur pre and post initiation of ICI and thereby potentially identify early cardiotoxicity in patients who might be more prone to more devastating IRAEs such as myocarditis., 6 weeks
Researchers are trying to determine the side effects on the heart from immune checkpoint inhibitor (ICI) treatment in patients with cancer.